Asset Details
Do you wish to reserve the book?
Cellular signaling and NO production
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Cellular signaling and NO production
Do you wish to request the book?
Cellular signaling and NO production
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Cellular signaling and NO production
2010
Overview
The endothelium can evoke relaxations (dilatations) of the underlying vascular smooth muscle, by releasing vasodilator substances. The best characterized endothelium-derived relaxing factor is nitric oxide (NO), which is synthesized by the endothelial isoform of nitric oxide synthase (eNOS). Endothelium-dependent relaxations involve both pertussis-toxin-sensitive G
i
(e.g., responses to serotonin, sphingosine 1-phosphate, alpha
2
-adrenergic agonists, and thrombin) and pertussis-toxin-insensitive G
q
(e.g., adenosine diphosphate and bradykinin) coupling proteins. eNOS undergoes a complex pattern of intracellular regulation, including post-translational modifications involving enzyme acylation and phosphorylation. eNOS is reversibly targeted to signal-transducing plasmalemmal caveolae where the enzyme interacts with a number of regulatory proteins, many of which are modified in cardiovascular disease states. The release of nitric oxide by the endothelial cell can be up- (e.g., by estrogens, exercise, and dietary factors) and down-regulated (e.g. oxidative stress, smoking, and oxidized low-density lipoproteins). It is reduced in the course of vascular disease (e.g., diabetes and hypertension). Arteries covered with regenerated endothelium (e.g. following angioplasty) selectively lose the pertussis-toxin-sensitive pathway for NO release which favors vasospasm, thrombosis, penetration of macrophages, cellular growth, and the inflammatory reaction leading to atherosclerosis. The unraveling of the complex interaction of the pathways regulating the presence and the activity of eNOS will enhance the understanding of the perturbations in endothelium-dependent signaling that are seen in cardiovascular disease states, and may lead to the identification of novel targets for therapeutic intervention.
Publisher
Springer-Verlag,Springer Nature B.V
Subject
/ Adaptor Proteins, Signal Transducing
/ Animals
/ Biomedical and Life Sciences
/ Carrier Proteins - physiology
/ Coronary Disease - physiopathology
/ Endothelium, Vascular - drug effects
/ Endothelium, Vascular - physiology
/ Gene Expression Regulation, Enzymologic
/ HSP90 Heat-Shock Proteins - physiology
/ Humans
/ Hypercholesterolemia - physiopathology
/ Hypertension - physiopathology
/ Intracellular Signaling Peptides and Proteins - physiology
/ Nitric Oxide Synthase Type III - metabolism
/ Protein Processing, Post-Translational
/ Proteins
